Korea's VIG makes first full exit from Fund III
VIG Partners has agreed to exit its 51% stake in eyewear brand Star Vision through a buyback by the South Korean company’s founder and current minority shareholder.
The transaction value will be finalized following confirmatory due diligence on Star Vision’s 2021 financial performance, but VIG expects to generate an approximately 2x return. This will be the first...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.